Format

Send to

Choose Destination
Lancet Diabetes Endocrinol. 2016 Aug;4(8):649-50. doi: 10.1016/S2213-8587(16)30151-6. Epub 2016 Jul 1.

EU regulation of endocrine disruptors: a missed opportunity.

Author information

1
Brunel University London, Institute of Environment, Health and Societies, Uxbridge UB8 3PH, UK. Electronic address: andreas.kortenkamp@brunel.ac.uk.
2
Pediatric Endocrinology, CHU Liège and Neuroendocrinology Unit, GIGA Neurosciences, University of Liège, Liège, Belgium.
3
Inserm, CNRS and University Grenoble Alpes, IAB Joint Research Center, Team of Environmental Epidemiology, Grenoble, France.
4
Swedish Toxicology Sciences Research Center, Södertälje, Sweden.
5
UMR CNRS/MNHN 7221, Department RDDM, Muséum National d'Histoire Naturelle, Paris, France.
6
School of Biosciences & School of Veterinary Medicine and Science, University of Nottingham, UK.
7
Department of Neuroscience, University of Torino, Orbassano, Italy; Neuroscience Institute Cavalieri Ottolenghi, Orbassano, Italy.
8
Departments of Pediatrics, Environmental Medicine and Population health, New York University School of Medicine, New York, New York, USA.
9
University of Massachusetts, Biology Department, Amherst, MA, USA.
PMID:
27377541
DOI:
10.1016/S2213-8587(16)30151-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center